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EFFECTS OF EXOGENOUS LACTOFERRIN ON PHENOTYPIC 
PROFILE AND INVASIVENESS OF HUMAN PROSTATE CANCER 
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Aim: To investigate the biological effects of exogenous lactoferrin (LF) on phenotypic profile and invasiveness of human prostate 
cancer (PC) cells in vitro. Materials and Methods: Human PC cell lines (LNCaP, DU-145) were cultured with an exogenous 
LF at a dose corresponding to IC30. The expression levels of steroid hormone receptors (androgen receptor, estrogen receptor, 
progesterone receptor), Her2/neu, Ki-67, E- and N-cadherin, were monitored by immunohistochemical analysis. The levels 
of miRNAs were assessed using q-PCR. The invasive activity of the cells was examined in a standard invasion test. Results: Exogenous 
LF reduced expression of steroid hormone receptors (ERα and PR) and Ki-67 in both PC cell lines. The expression of E-cadherin 
increased significantly in LF-treated DU-145 cells. Also, we established the decrease in invasive activity upon LF treatment by 40% 
and 30% in DU-145 and LNCaP cells, respectively. In DU-145 cells, incubation with exogenous LF resulted in an increase in the 
expression of oncosuppressive (miR-133a and miR-200b) miRNAs. Conclusions: Exogenous LF causes the changes in phenotypic 
characteristics of PC cells and levels of oncogenic and oncosuppressive miRNAs involved in the regulation of key cellular processes.
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Prostate cancer (PC) is one of the most common 
malignant neoplasms among men worldwide [1]. 
To date, novel methods of treatment have been 
deve loped and introduced into clinical practice; multi-
center studies of the treatment of PC of various stages 
and types are being conducted. However, despite all 
the advances in the treatment, PC-related morbidity 
and mortality increase worldwide [1–3].
Due to the lack of early symptoms, PC is usually 
diagnosed at the late stages, when surgical interven-
tion is impossible and conservative therapy is unsuc-
cessful. D’Amico et al. [4] proposed a classification 
of PC that ascribes the patients with a level of prostate 
specific antigen > 20 ng/ml, Gleason score of 8–10, 
or a clinical stage ≥ T2c to a high risk group or cancer 
with a high degree of malignancy. The validity of this 
classification recommended by the American Uro-
logical Association [5] has been proved in a number 
of studies [6, 7]. Historically, the impossibility of ef-
fective treatment of highly malignant PC via a single 
radical prostatectomy has led to greater use of other 
therapeutic options, such as hormonal therapy 
as single modality or combined with radiotherapy [7].
Nowadays throughout the world, there is a search 
and development of approaches to reduce the degree 
of malignancy of PC by modifying the phenotype 
of tumor cells. It is considered promising to use the 
compounds with antioxidant properties, in particular, 
lactoferrin (LF). By its origin, LF is an iron-binding gly-
coprotein from the transferrin family, which carries iron 
to the cells and controls the level of “free” iron in the 
blood and biological fluids [8, 9]. LF identified in blood 
plasma is one of the main components of almost all 
exocrine secretions of mammals such as saliva, bile, 
tears, pancreatic secretion, etc. [8–10]. LF is repre-
sented by three molecular isoforms — LF-α, LF-β, 
LF-γ, two of which — LF-α, LF-β have ribonuclease 
activity [9]. LF molecule is highly resistant to proteo-
lytic degradation by trypsin-like enzymes [10, 11]. 
This protein is well-known for its multiple biological 
functions such as antibacterial, antiviral, anti-tumor, 
anti-inflammatory, immunoregulatory properties, and 
also interacts with polyamines, heparin, DNA, and 
RNA [12]. In our previous studies in vitro, on the model 
of human breast cancer, it was found that LF disrupts 
the prooxidant/antioxidant balance by increasing the 
level of active forms of oxygen, “free iron” and the 
rate of NO generation. These disorders lead to block-
age of the cell cycle in the G2/M phase and the death 
of malignant cells by apoptosis [13]. In vivo studies 
have shown that LF delays appearance of primary 
tumors and inhibits the growth rate of an experimen-
tal cervical cancer in mice [14, 15]. However, in the 
available literature, there are only few reports devoted 
to the study of molecular biological effects of LF on the 
of human PC cell lines.
The aim of the work was to investigate the biologi-
cal effects of exogenous LF on phenotypic profile and 
invasiveness of human PC cells in vitro.
MATERIALS AND METHODS
Cell lines. Two human PC cell lines DU145 and 
LNCaP were provided by the Bank of Cell Lines of Hu-
man and Animal Tissues at R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and Radiobiol-
ogy of the NAS of Ukraine. DU145 and LNCaP cells 
were grown in DMEM (Invitrogen, USA) supplemented 
with 10% fetal bovine serum (Gibco/Invitrogen, USA) 
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at 37 °C in a humidified atmosphere with 5% CO2 and 
subcultured after reaching 80% of flask surface. In all 
experiments of this study, cells in log phase were 
subcultured for 24 h and the medium was replaced 
with fresh medium with or without reagents.
Lactoferrin. Recombinant human LF was kindly 
provided by the colleagues from the Institute of Physio-
logy of the National Academy of Sciences of Belarus 
in the framework of the joint research project funded 
by the NAS of Ukraine and the NAS of Belarus “Molecu-
lar biological effects and mechanisms of lactoferrin in-
fluence on tumor cells in in vitro and in vivo systems” — 
Contract No. 07-04-15 [16]. LF was diluted in PBS and 
added directly to the culture medium at a dose corre-
sponding to IC30. Cells were cultured with LF during 48 h.
Immunocytochemical methods. Cells for immu-
nocytochemical studies were grown on glass cover 
slips, fixed in cooled mixture of methanol:acetone 
(1:1) at −20 °C for 120 min, washed in PBS and incu-
bated with 1% BSA for 20 min. The following primary 
monoclonal antibodies were used: anti-androgen re-
ceptor (Thermo Scientific, USA); anti-estrogene α re-
ceptor (Thermo Scientific, USA); anti-estrogene β re-
ceptor (Thermo Scientific, USA); anti-progesterone 
receptor (Thermo Scientific, USA); anti-Кi-67 (Dako 
Cytomation, Denmark); anti-E-cadherin (Thermo 
Scientific, USA), anti-EerbB2 (Thermo Scientific, 
USA); anti-CD325 (N-Cadherin) (Dako Cytomation, 
Denmark). The antibodies diluted in the blocking 
buffer were added to the cell specimens for one hour 
followed by incubation with Ultra Vision LP Detection 
System (Lab Vision, Thermo Scientific). After the 
washing, the immune reaction was visualized using 
DAB Quanto (Thermo Scientific). When immunocy-
tochemical reactions were completed, the cells were 
stained with hematoxylin by Mayer for 10–15 s and 
placed in Faramount Aqueous Mounting Medium 
(Dako Cytomation, Denmark). The results were evalu-
ated in 3 visual fields by light microscopy (× 100, oil 
immersion) using the classical H-Score method: 
S = 1 • N1+ + 2 • N2+ + 3 • N3+, 
where S is «H-Score» index; N1+, N2+ and N3+ are 
numbers of cells with low, medium or high levels 
of marker expression. It should be noted that in previ-
ous studies we have identified biomolecular markers 
that characterize the metastatic potential and invasive 
activity of PC cells of abovementioned lines [17].
Invasive activity was investigated using a standard 
method with the matrigel membranes (BD BioCoat™ 
Matrigel™ Invasion Chamber, Bedford, USA) with pore 
sizes of 8 microns, according to manufacturer’s rec-
ommendations. In the upper part of the membrane, 
the cell suspension was placed in a concentration 
of 5 • 104 cells/well in culture medium without bovine 
serum. In the lower part, the standard culture medium 
supplemented with 10% fetal bovine serum was intro-
duced. The cells were then incubated under standard 
conditions at the temperature of 37 °C in humidified 
atmosphere with 5% CO2 during 48 hours. The mem-
branes were then fixed with methanol followed by stain-
ing with crystal violet B and the cells invading through 
membrane were counted on the outside of membrane 
using light microscopy (× 100, oil immersion).
Total RNA isolation. Total RNA extraction was 
performed using Ribozol RNA Isolation Kit (Ampli-
sens, Russia). Concentration of RNA was measured 
using NanoDrop 2000c Spectrophotometer (Thermo 
Scientific, USA). The purity of isolated RNA was con-
trolled by OD ratio at 260/280 nm. RNA was dissolved 
in TE buffer and stored at −20 °С. Single-stranded 
cDNA was synthesized from 100 ng of total RNA, using 
TaqMan® MicroRNA Kit (Applied Biosystems, USA) for 
reverse transcription.
Real-time quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). Preparation 
of reverse transcription reaction mix was performed ac-
cording to manufacturer’s protocol. Reverse transcrip-
tion was performed at a “Tertsik” (DNA Tehnologіya, 
Russian Federation) thermal cycler. qRTPCR was per-
formed on Applied Biosystems 7900HT Fast Real-Time 
PCR System using TaqMan® MicroRNA primers (Applied 
Biosystems, USA) and Maxima SYBR Green/ROX qPCR 
Master Mix (2X) (Thermo Scientific, USA) by manufac-
turer’s protocol. Small nucleolar RNA RNU48 was used 
as an endogenous control for normalization of miRNA 
expression. Relative expression of the studied miRNAs 
was identified by comparative Ct method. Experiments 
were performed in triplicates for each line, and PCR was 
performed three times for each sample. Expression 
differences between the studied miRNA levels relative 
to control was calculated by the formula: 
Fold change = 2−ΔΔCt, 
where ΔCt (target — control) is equal to the dif-
ference between threshold cycles for miRNA (target) 
and the threshold cycle for RNU48 (control) ΔCt (tar-
get — control) = Ct target − Ct control). ΔΔCt = ΔCt 
(experiment) − ΔCt (control).
Statistical analysis  was performed using 
STATISTICA 6.0 software (StatSoft Inc., USA). All data 
were obtained in triplicates. The values were expressed 
as means ± standard deviation (SD). Student’s t-test 
was used to evaluate the significance of the diffe-
rences between groups. A value of p < 0.05 was ac-
cepted as statistically significant.
RESULTS
Phenotypic characteristics of DU-145 and 
LNCaP cells. We have found that DU-145 and LNCaP 
cell lines were characterized by the presence of ste-
roid hormones receptors and HER2/neu (Table 1). 
The high level of androgen receptor (AR) expression 
was established in DU-145 cells (282.0 ± 14.0 points 
by the H-Score) and in LNCaP (270.0 ± 8.0 points 
by the H-Score). In the cells of both studied lines, 
high expression level of estrogen receptor (ER)β, low 
level of ERα and medium level of progesterone recep-
tor (PR) were detected. No significant differences 
were found between the expression of HER2/neu 
in the DU-145 and LNCaP lines (84.0 ± 11.3 and 
94.0 ± 4.0 points by H-Score, respectively).
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Table 1. Molecular profile of human PC cells of DU-145 and LNCaP lines
DU-145 LNCaP
Receptor status
AR 282.0 ± 14.0 270.0 ± 8.0
ERα 80.0 ± 13.0 98.0 ± 12.0
ERβ 276.0 ± 9.3 280.0 ± 10.6
PR 117.0 ± 18.0 150.0 ± 17.6
HER2/neu 84.0 ± 11.3 94.0 ± 4.0
Markers of intercellular adhesion
E-cadherin 35.0 ± 6.6 3.0 ± 1.0
N-cadherin 175.0 ± 12.7* 247.0 ± 11.6
Markers of proliferative activity
Ki-67 265.0 ± 20.5* 174.0 ± 24.6
Invasive activity, ×10³ cells
0.387 ± 0.005* 0.076 ± 0.007
Note: *p < 0.05 compared with LNCaP cells.
The study of adhesive properties demonstrated 
a low expression of E-cadherin in the cells of the stud-
ied lines (Table 1), while the expression of N-cadherin 
in DU-145 cells was significantly lower than that 
in the LNCaP cells (175 ± 12.7 and 247 ± 11.6 points 
by H-Score, respectively).
DU-145 cells also showed significantly higher 
rates of proliferative (Ki-67 — 265.0 ± 20.5 points 
by the H-Score) and invasive activity (0.387 • 103 cells) 
compared to LNCaP cells in which the level Ki-67 was 
174.0 ± 24.6 points by the H-Score, and the invasive 
activity value was 0.076 • 103 cells (Table 1).
miRNA profile in DU-145 and LNCaP cells. Us-
ing the resource http://mirbase.org, we have chosen 
a panel of micro-RNAs involved in the oncogenesis 
of human PC and in regulation of the expression of ste-
roid hormones receptors (miRNA-205 and miRNA-155), 
intercellular adhesion proteins (miRNA-200b), prolif-
erative (miRNA-133a) and invasive (miRNA-205) 
activity [18, 19]. According to our data (Fig. 1), the 
level of miRNA-205 was significantly higher in cells 
of the DU-145 line compared to the LNCaP line 
(0.250 ± 0.010 and 0.208 ± 0.011 a.u., respectively). 
It was found that the levels of miRNA-155 in the studied 
cell lines did not differ significantly.
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Fig. 1. miRNA expression in human PC cell lines. *p < 0.05 com-
pared with LNCaP cells
The level of miRNA-133a was significantly higher 
in DU-145 cells (0.245 ± 0.010 a.u.) compared to the 
LNCaP line for which this index was 0.029 ± 0.009 a.u. 
There were no differences in the levels of miRNA-200b 
in these cells (Fig. 1).
Effect of exogenous LF on the expression level 
of the miRNA in the human PC cell lines. At the next 
stage of our study we have analyzed the effect of exog-
enous LF on the level of miRNAs expression in the cells 
of human PC cell lines. It was found that under the action 
of exogenous LF in both cell lines there was an increase 
in the expression of miRNA-205 and miRNA-155 (Fig. 2).
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Fig. 2. The effect of exogenous LF on the level of miRNAs ex-
pression in the cells of human PC cell lines. *p < 0.05 compared 
with the control
The most significant changes in the expres-
sion of miRNA-205 expression were detected 
in DU-145 cells, in particular, its level increased 
up to 344.89 ± 1.34 a.u. In LNCaP cells, the level 
of miRNA-205 increased up to 0.318 ± 0.010 a.u. A sim-
ilar pattern was also established for miRNA-155, the 
level of expression of which under the action of LF in-
creased to 194.35 ± 1.25 a.u. and 0.034 ± 0.001 a.u. 
in the DU-145 and LNCaP cell lines, respectively.
Cultivation of the DU-145 cells with exogenous 
LF resulted in a significant increase in the expres-
sion of miR-200b (up to 143.01 ± 1.28 a.u.) and 
miRNA-133a (up to 261.38 ± 1.418 a.u.). In the LNCaP 
cells, the change of expression of these miRNAs was 
reversed, namely, decreased to 0.009 ± 0.002 a.u. and 
0.004 ± 0.001 a.u., respectively.
Effect of exogenous LF on phenotypic char-
acteristics of human PC cell lines. Next, we have 
studied the modifying effect of exogenous LF on the 
molecular profile of human PC cells. Taking into ac-
count the importance of steroid hormones receptors 
in carcinogenesis [20, 21], we have studied the effect 
of exogenous LF on their expression in the cells of the 
PC lines.
It was established that cultivation of both cell lines 
with exogenous LF did not lead to a significant change 
in AR level (Fig. 2). It was found that under the action 
of LF there was a decrease (almost double) of the ex-
pression level of ERα (up to 47.3 ± 7.3 points by H-Score 
for DU-145 cells and 55.0 ± 10.0 points by H-Score 
for LNCaP cells). Similar changes were also observed 
for PR, whose expression level after cultivation in the 
presence of LF was 60.0 ± 11.3 and 78.0 ± 13.0 points 
by H-Score in DU-145 and LNCaP cells, respectively 
(Fig. 3, 4).
As can be seen from the data shown in Fig. 5, 
the cultivation of DU-145 cells with exogenous LF re-
sulted in an increase in the expression of E-cadherin 
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by 5.3 times, up to 186.3 ± 13.0 points by H-Score. There 
was no change in the level of another molecule of inter-
cellular adhesion, N-cadherin, whose expression rates 
were 175.0 ± 14.3 and 214.0 ± 16.0 points by H-Score 
in DU-145 and LNCaP cells, respectively.
Exogenous LF decreases the indices of proliferative 
and invasive activity of the cells of both investigated 
lines (Table 2). In particular, the level of Ki-67 expression 
under the influence of exogenous LF decreased by 41% 
and 50% in DU-145 and LNCaP cell lines, respectively. 
Similar changes were observed with the indices of inva-
sive activity, which decreased by almost 40% and 30% 
in DU-145 and LNCaP cell lines, respectively.
Table 2. Influence of exogenous LF on indices of proliferative and invasive 
activity of human PC cells
Cell line Ki-67, H-score points Invasive activity, •103 cells
DU-145 Control 265.0 ± 20.5 0.387 ± 0.005
LF 156.0 ± 14.6* 0.234 ± 0.002*
LNCaP Control 174.0 ± 24.6 0.076 ± 0.007
LF 87.3 ± 15.7* 0.054 ± 0.004*
Note: *p < 0.05 compared with the control.
DISCUSSION
We have analyzed the effects of exogenous 
LF on phenotypic profile and invasiveness in two hu-
man PC cell lines. DU-145 and LNCaP cells were both 
derived from PC metastases. DU-145 cells — from 
brain metastases of aggressive PC [22] and LNCaP 
cells — from the metastases in the supraclavicular 
lymph node [23]. DU-145 cells are hormone-refractory 
and do not express a prostate-specific antigen [22, 24, 
25]. The xenografts of DU-145 cells exhibit moderate 
potential for metastasizing [26]. Hormone-sensitive 
LNCaP cells contain high-affinity cytoplasmic and 
nuclear androgen receptors and estrogen receptors 
in cytoplasm. Usually, it is used for the study as an-
drogen-sensitive prostate adenocarcinoma [27, 28].
Insensitivity to antiandrogen therapy of DU-145 cell 
line may be explained by the expression of alternative 
splice-variant of AR — AR3, which provides ablation-
independent growth of PCA cells. Also, AR3 can play 
an important role in this type of growth by regulation 
of unique set of genes, including AKT1, which are not 
controlled by prototype AR [29].
We have shown that DU-145 and LNCaP cell lines 
have similar expression profile of steroid hormones re-
ceptors, and HER2/neu. Nevertheless, such two lines 
differ in E-cadherin and Ki-67 expression and differ 
markedly by invasive activity assayed in vitro that may 
be suggestive of their putative differences in the degree 
of malignancy. Taking into account the importance of the 
epigenetic component in acquiring the degree of malig-
nancy, we analyzed the levels of the miRNAs in human 
PC cells. DU-145 cells are characterized by higher levels 
of oncogenic miRNA-205 and miRNA-155. In LNCaP 
cells, significantly higher level of oncosuppressive 
miRNA-133a was detected. So, we have established that 
human PC cell lines under study differ in their adhesive 
and invasive properties, as well as the level of proliferative 
activity. The different phenotypic profiles of DU-145 and 
LNCaP cell lines may suggest the difference in malignant 
potential of these cells.
Exogenous LF induces similar shifts in the phe-
notypic profile of both cell lines decreasing ERα and 
PR expression and increasing expression of E-cadherin 
with different magnitude of the effects in each cell line. 
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Fig. 5. Effect of exogenous LF on the expression level of intercel-
lular adhesion molecules in human PC cells. *p < 0.05 compared 
with the control
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Fig. 3. The level of expression of steroid hormones receptors 
in the cells of human PC cell lines under the influence of exo-
genous LF. *p < 0.05 compared with control
Fig. 4. The effect of exogenous LF on the molecular profile 
of human PC cells
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In both cell lines, exogenous LF also increases the ex-
pression of miRNA-205 and miRNA-155, which are in-
volved in regulating the expression of steroid hormones 
receptors, while the levels of miR-133a and miR-200b 
miRNAs were increased only in LF-treated DU-145 cells. 
According to the literature [30], miRNA-155 regulates 
the synthesis of such proinflammatory cytokines 
as IL-1 and IL-6 resulting in a decrease in the expres-
sion of ERα and PR, confirmed by our own studies. The 
results obtained are important given that estrogens 
can affect the carcinogenesis in the prostate through 
ERα-mediated signaling, being the part of a group of so-
called hormonal nuclear receptors, and can interact 
directly with certain domains of genomic DNA by acti-
vating/blocking the transcription of target genes [20]. 
According to clinical observations, a high level of ERα 
is detected in the hormone-refractory PC, both in the 
primary lesion and in metastases. It should be noted 
that similar data were obtained by Ha et al. who found 
that cultivation of cells with exogenous LF is associated 
with decreased expression of ERα and PR [31].
ERα is also one of the key determinants of cell cycle 
regulation, acting by inhibiting p53/p21 and increasing 
the expression of PCNA and Ki-67. In view of this, reduc-
tion of ERα expression, which was observed after cultur-
ing cells with exogenous LF, may result in the inhibition 
of proliferation [32]. We have shown that the treatment 
of DU-145 cells with LF leads to an increase in the level 
of miRNA-133a, an inhibitor of proliferative activity.
Another mechanism for regulating proliferation, 
according to Mariller et al. [33], can be the direct bind-
ing of LF to the promoter of the Skp1 gene with further 
activation of its expression. Exogenous LF has been 
shown to reduce the expression of cyclins D1 and/
or D4 that take part in the cell transition to the S-phase. 
The studies have shown that the cause of growth retar-
dation may be the blocking of the cell cycle in the G0/
G1 phase. A similar effect of LF on the cell cycle was 
also demonstrated on the model of the nasopharyn-
geal carcinoma. In this case, the expression of cyclin 
D1 decreased, while the expression of p21 and p27 in-
creased [32–34].
Exogenous LF also causes the increase in the ex-
pression of miRNA-200b involved in regulating expres-
sion of the intercellular adhesion molecule E-cadherin. 
The increase of E-cadherin expression after cultivation 
of cells with exogenous LF can also occur due to the 
changes in ERα/ERβ ratio [35]. As a result, the invasive 
activity of the cells decreases. It is worth noting that 
for the numerous types of malignant tumors, including 
PC, E-cadherin expression correlates with more favor-
able prognosis. It is believed that the decrease or loss 
of E-cadherin expression correlates with invasiveness 
of the tumor, the formation of distant metastases, and 
unfavorable clinical prognosis [36, 37].
In conclusion, we have demonstrated that exog-
enous LF triggers the changes in phenotypic charac-
teristics of PC cells and the expression of oncogenic 
Fig. 6. Mechanism of action of exogenous LF on human PC cells
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and oncosuppressive miRNAs involved in the regula-
tion of key cellular processes. Several putative targets 
of LF in PC cells are summarized in Fig. 6. Undoubtedly, 
further studies will ascertain the mechanisms of action 
of exogenous LF on human PC cells.
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